203 related articles for article (PubMed ID: 37732493)
21. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.
Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM
Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391
[TBL] [Abstract][Full Text] [Related]
22. A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
Li X; Xiong F; Hu Z; Tao Q; Yang Y; Qiao X; Peng C; Jiang Y; Han M; Dong K; Hua Y; Zhang W; Xu M; Long W; Xiao Y; Wang D
J Transl Med; 2024 Jan; 22(1):90. PubMed ID: 38254099
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.
Han S; Tay JK; Loh CJL; Chu AJM; Yeong JPS; Lim CM; Toh HC
Front Immunol; 2021; 12():734293. PubMed ID: 34956172
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
[TBL] [Abstract][Full Text] [Related]
25. Identifying the key genes of Epstein-Barr virus-regulated tumour immune microenvironment of gastric carcinomas.
Zhou H; Jing S; Liu Y; Wang X; Duan X; Xiong W; Li R; Peng Y; Ai Y; Fu D; Wang H; Zhu Y; Zeng Z; He Y; Ye Q
Cell Prolif; 2023 Mar; 56(3):e13373. PubMed ID: 36519208
[TBL] [Abstract][Full Text] [Related]
26. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
Nagpal P; Descalzi-Montoya DB; Lodhi N
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
[TBL] [Abstract][Full Text] [Related]
27. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8
Tang F; Chen JN; Zhang NN; Gong LP; Jiang Y; Feng ZY; Xiao L; Li HG; Du H; Wu B; Shao CK
Pathology; 2018 Oct; 50(6):613-621. PubMed ID: 30149990
[TBL] [Abstract][Full Text] [Related]
28. Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms.
Cheng N; Hui DY; Liu Y; Zhang NN; Jiang Y; Han J; Li HG; Ding YG; Du H; Chen JN; Shao CK
Gastric Cancer; 2015 Apr; 18(2):246-55. PubMed ID: 24771002
[TBL] [Abstract][Full Text] [Related]
29. Estimating the Global Burden of Epstein-Barr Virus-Associated Gastric Cancer: A Systematic Review and Meta-Analysis.
Hirabayashi M; Georges D; Clifford GM; de Martel C
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):922-930.e21. PubMed ID: 35963539
[TBL] [Abstract][Full Text] [Related]
30. Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
Moore A; Hikri E; Goshen-Lago T; Barkan T; Morgenstern S; Brook E; Maderer A; Roth W; Gordon N; Kashtan H; Brenner B; Moehler M; Aharon IB
BMC Cancer; 2020 Jan; 20(1):34. PubMed ID: 31937281
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma.
Li W; Lv S; Liu G; Lu N; Jiang Y; Liang H; Xia W; Xiang Y; Xie C; He J
Front Immunol; 2023; 14():1124066. PubMed ID: 36860875
[TBL] [Abstract][Full Text] [Related]
32. Gastric cancer with distinct Epstein-Barr virus-positive and -negative tumor components and their whole exome sequencing result: a case Report.
Park KB; Seo AN; Kim M
Diagn Pathol; 2023 Jul; 18(1):81. PubMed ID: 37434198
[TBL] [Abstract][Full Text] [Related]
33. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
[TBL] [Abstract][Full Text] [Related]
34. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B
Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918
[TBL] [Abstract][Full Text] [Related]
35. Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
Larbcharoensub N; Mahaprom K; Jiarpinitnun C; Trachu N; Tubthong N; Pattaranutaporn P; Sirachainan E; Ngamphaiboon N
Am J Clin Oncol; 2018 Dec; 41(12):1204-1210. PubMed ID: 29672367
[TBL] [Abstract][Full Text] [Related]
36. The immune escape mechanism of nasopharyngeal carcinoma.
Li X; Guo Y; Xiao M; Zhang W
FASEB J; 2023 Jul; 37(7):e23055. PubMed ID: 37358482
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes.
Saiki Y; Ohtani H; Naito Y; Miyazawa M; Nagura H
Lab Invest; 1996 Jul; 75(1):67-76. PubMed ID: 8683941
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan.
Harn HJ; Chang JY; Wang MW; Ho LI; Lee HS; Chiang JH; Lee WH
Hum Pathol; 1995 Mar; 26(3):267-71. PubMed ID: 7890276
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
40. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Strong MJ; Xu G; Coco J; Baribault C; Vinay DS; Lacey MR; Strong AL; Lehman TA; Seddon MB; Lin Z; Concha M; Baddoo M; Ferris M; Swan KF; Sullivan DE; Burow ME; Taylor CM; Flemington EK
PLoS Pathog; 2013; 9(5):e1003341. PubMed ID: 23671415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
